1
|
Song Y, Zhang HJ, Song X, Geng J, Li HY, Zhang LZ, Yang B, Lu XC. Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma. World J Clin Oncol 2024; 15:115-129. [PMID: 38292661 PMCID: PMC10823940 DOI: 10.5306/wjco.v15.i1.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/20/2023] [Revised: 12/13/2023] [Accepted: 01/02/2024] [Indexed: 01/23/2024] Open
Abstract
BACKGROUND Multiple myeloma (MM) is a terminal differentiated B-cell tumor disease characterized by clonal proliferation of malignant plasma cells and excessive levels of monoclonal immunoglobulins in the bone marrow. The translocation, (t)(4;14), results in high-risk MM with limited treatment alternatives. Thus, there is an urgent need for identification and validation of potential treatments for this MM subtype. Microarray data and sequencing information from public databases could offer opportunities for the discovery of new diagnostic or therapeutic targets. AIM To elucidate the molecular basis and search for potential effective drugs of t(4;14) MM subtype by employing a comprehensive approach. METHODS The transcriptional signature of t(4;14) MM was sourced from the Gene Expression Omnibus. Two datasets, GSE16558 and GSE116294, which included 17 and 15 t(4;14) MM bone marrow samples, and five and four normal bone marrow samples, respectively. After the differentially expressed genes were identified, the Cytohubba tool was used to screen for hub genes. Then, the hub genes were analyzed using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis. Using the STRING database and Cytoscape, protein-protein interaction networks and core targets were identified. Potential small-molecule drugs were identified and validated using the Connectivity Map database and molecular docking analysis, respectively. RESULTS In this study, a total of 258 differentially expressed genes with enriched functions in cancer pathways, namely cytokine receptor interactions, nuclear factor (NF)-κB signaling pathway, lipid metabolism, atherosclerosis, and Hippo signaling pathway, were identified. Ten hub genes (cd45, vcam1, ccl3, cd56, app, cd48, btk, ccr2, cybb, and cxcl12) were identified. Nine drugs, including ivermectin, deforolimus, and isoliquiritigenin, were predicted by the Connectivity Map database to have potential therapeutic effects on t (4;14) MM. In molecular docking, ivermectin showed strong binding affinity to all 10 identified targets, especially cd45 and cybb. Ivermectin inhibited t(4;14) MM cell growth via the NF-κB pathway and induced MM cell apoptosis in vitro. Furthermore, ivermectin increased reactive oxygen species accumulation and altered the mitochondrial membrane potential in t(4;14) MM cells. CONCLUSION Collectively, the findings offer valuable molecular insights for biomarker validation and potential drug development in t(4;14) MM diagnosis and treatment, with ivermectin emerging as a potential therapeutic alternative.
Collapse
Affiliation(s)
- Yang Song
- School of Basic Medicine, Medical School of Chinese PLA, Beijing 100853, China
| | - Hao-Jun Zhang
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
| | - Xia Song
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
| | - Jie Geng
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
| | - Hong-Yi Li
- School of Basic Medicine, Medical School of Chinese PLA, Beijing 100853, China
| | - Li-Zhong Zhang
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
| | - Bo Yang
- Department of Hematology, The Second Medical Centre, Chinese PLA General Hospital, Beijing 100853, China
| | - Xue-Chun Lu
- Department of Hematology, The Second Medical Centre, Chinese PLA General Hospital, Beijing 100853, China
| |
Collapse
|
2
|
Wang ZN, Chen HR, Zhang JD, Lu XC. [Omics Analysis of Ferroptosis and Establishment of Prognostic Model for multiple myeloma Patients]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2023; 31:411-419. [PMID: 37096513 DOI: 10.19746/j.cnki.issn.1009-2137.2023.02.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
Abstract
OBJECTIVE To explore the role of ferroptosis-related genes in multiple myeloma(MM) through TCGA database and FerrDb, and build a prognostic model of ferroptosis-related genes for MM patients. METHODS Using the TCGA database containing clinical information and gene expression profile data of 764 patients with MM and the FerrDb database including ferroptosis-related genes, the differentially expressed ferroptosis-related genes were screened by wilcox.test function. The prognostic model of ferroptosis-related genes was established by Lasso regression, and the Kaplan-Meier survival curve was drawn. Then COX regression analysis was used to screen independent prognostic factors. Finally, the differential genes between high-risk and low-risk patients were screened, and enrichment analysis was used to explore the mechanism of the relationship between ferroptosis and prognosis in MM. RESULTS 36 differential genes related to ferroptosis were screened out from bone marrow samples of 764 MM patients and 4 normal people, including 12 up-regulated genes and 24 down-regulated genes. Six prognosis-related genes (GCLM, GLS2, SLC7A11, AIFM2, ACO1, G6PD) were screened out by Lasso regression and the prognostic model with ferroptosis-related genes of MM was established. Kaplan-Meier survival curve analysis showed that the survival rate between high risk group and low risk group was significantly different(P<0.01). Univariate COX regression analysis showed that age, sex, ISS stage and risk score were significantly correlated with overall survival of MM patients(P<0.05), while multivariate COX regression analysis showed that age, ISS stage and risk score were independent prognostic indicators for MM patients (P<0.05). GO and KEGG enrichment analysis showed that the ferroptosis-related genes was mainly related to neutrophil degranulation and migration, cytokine activity and regulation, cell component, antigen processing and presentation, complement and coagulation cascades, haematopoietic cell lineage and so on, which may affect the prognosis of patients. CONCLUSION Ferroptosis-related genes change significantly during the pathogenesis of MM. The prognostic model of ferroptosis-related genes can be used to predict the survival of MM patients, but the mechanism of the potential function of ferroptosis-related genes needs to be confirmed by further clinical studies.
Collapse
Affiliation(s)
- Zi-Ning Wang
- Medical School of Chinese PLA, Beijing 100853, China; Department of Hematology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China
| | - Hao-Ran Chen
- School of Management, Shanxi Medical University, Taiyuan 030604, Shanxi Province, China
| | - Jun-Dong Zhang
- Medical School of Chinese PLA, Beijing 100853, China; Department of Hematology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China
| | - Xue-Chun Lu
- Department of Hematology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China. E-mail:
| |
Collapse
|
3
|
Li HY, Zhang JD, Lu XC. [Clinical Research Advances of Duodenal-Type Follicular Lymphoma--Review]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2023; 31:581-584. [PMID: 37096537 DOI: 10.19746/j.cnki.issn.1009-2137.2023.02.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
Abstract
Duodenal-type follicular lymphoma (DFL) is a unique subtype of follicular lymphoma (FL), which often involves the second portion of duodenum (descending part of duodenum). Due to its specific pathological features, such as lack of follicular dendritic cells meshwork and disappearance of activation-induced cytidine deaminase expression, DFL presents an inert clinical course and is often confined to the intestinal tract. Inflammation-related biomarkers suggest that the microenvironment may play a likely role in the pathogenesis and favorable prognosis of DFL. Since patients generally have no obvious clinical symptoms and low progression rate, the treatment regimen for DFL is mainly observation and waiting (W&W) strategy. This study will review the latest research progress of epidemiology, diagnosis, treatment and prognosis of DFL in recent years.
Collapse
Affiliation(s)
- Hong-Yi Li
- Medical School of Chinese PLA; Department of Hematology, The Second Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Geriatric Disease, Beijing 100853, China
| | - Jun-Dong Zhang
- Medical School of Chinese PLA; Department of Hematology, The Second Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Geriatric Disease, Beijing 100853, China
| | - Xue-Chun Lu
- Medical School of Chinese PLA; Department of Hematology, The Second Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Geriatric Disease, Beijing 100853, China .E-mail:
| |
Collapse
|
4
|
Guo ZY, Zhang WC, Tian YL, Zhang ZQ, Cao YR, Lu XC, Zhang TG. Design, modeling, and testing of a one degree of freedom manipulator with three-stage amplification mechanism. Rev Sci Instrum 2022; 93:123705. [PMID: 36586917 DOI: 10.1063/5.0127014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Accepted: 11/25/2022] [Indexed: 06/17/2023]
Abstract
The one degree of freedom (1-DOF) manipulator with nano-resolution is a significant component in the micro-/nano-manipulation. In order to simultaneously achieve a large stroke and high precision, a piezo-driven 1-DOF flexure-based manipulator consisting of an enhanced double Scott-Russell mechanism (EDSRM), a lever type mechanism, and a Z-shaped mechanism is proposed in this paper. Analytical models are developed to examine the kinetostatic and dynamic properties of the manipulator. A finite element analysis is further performed to evaluate the characteristics of the EDSRM and the complete manipulator. The prototype is fabricated on monolithic AL7075, and various experimental tests have been carried out to investigate the correctness of the modeling. The experimental results show that the proposed manipulator has a satisfactory amplification ratio, static stability, and dynamic performance.
Collapse
Affiliation(s)
- Z Y Guo
- College of Aeronautical Engineering, Civil Aviation University of China, Tianjin 300300, China
| | - W C Zhang
- General Business Department, China Automotive Technology and Research Center Huacheng Certification (Tianjin) Company Limited, Tianjin 300399, China
| | - Y L Tian
- Key Laboratory of Mechanism Theory and Equipment Design of Ministry of Education, Tianjin University, Tianjin 300072, China
| | - Z Q Zhang
- College of Aeronautical Engineering, Civil Aviation University of China, Tianjin 300300, China
| | - Y R Cao
- College of Aeronautical Engineering, Civil Aviation University of China, Tianjin 300300, China
| | - X C Lu
- College of Aeronautical Engineering, Civil Aviation University of China, Tianjin 300300, China
| | - T G Zhang
- College of Aeronautical Engineering, Civil Aviation University of China, Tianjin 300300, China
| |
Collapse
|
5
|
Zhang JD, Zhang HM, Lu D, Wang ZN, Chen HR, Lu XC. [Screening of Differential Expression Autophagy Genes Related to the Prognosis of Diffuse Large B-Cell Lymphoma and Establishment of an Autophagy Model]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2022; 30:1101-1108. [PMID: 35981368 DOI: 10.19746/j.cnki.issn.1009-2137.2022.04.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
OBJECTIVE To screen the differential expression of diffuse large B-cell lymphoma (DLBCL) autophagy-related gene (ARG), explore the mechanism of differential expression of autophagy gene (DEARG) in the occurrence and development of DLBCL and establish a prognostic model. METHODS Using the NCICCR database containing clinical information and gene expression profile data of 481 patients with DLBCL and the HADb database containing 232 ARGs, the differential expression of ARG in DLBCL was determined by R language, the relationship between ARG and the occurrence and development of DLBCL was analyzed by GO and KEGG, the polygene prognostic model was established by Cox regression algorithm, the survival curve was drawn by Kaplan-Meier method, and the reliability of the prognostic model was evaluated by ROC curve. RESULTS A total of 122 DEARGs were extracted from lymph node samples of 481 patients with DLBCL and 5 normal lymph nodes, including 4 up-regulated genes and 118 down-regulated genes. GO enrichment mainly focused on ontological annotations such as mitochondrial autophagy, autophagy regulation, and cell response to external stimuli. KEGG enrichment was mainly concentrated in cell senescence, NOD-like receptor signal pathway, PI3K-Akt signal pathway, and PD-1/PD-L1 signal pathway. Survival analysis was performed on 230 samples with complete clinical information. Univariate Cox analysis showed that 20 ARGs were significantly correlated with overall survival of DLBCL patients. Nine prognostic ARGs (HIF1A, CAPN1, ITPR1, PRKCQ, TRAIL, HDAC1, TSC2, NRG3, and MAPK3) were screened by multivariate Cox regression to establish DLBCL ARG prognostic model. Kaplan-Meier survival curve analysis showed that there was significant difference in survival rate between high risk group and low risk group (P<0.001). Multivariate Cox regression analysis showed that international prognostic index and risk value were independent prognostic indicators of DLBCL patients (P<0.05), the area under ROC curve was 0.762 and 0.747, respectively. CONCLUSION DLBCL ARG prognostic model can be used to predict the prognosis of patients, but it still needs to be confirmed by a large sample of clinical studies.
Collapse
Affiliation(s)
- Jun-Dong Zhang
- Medical School of Chinese PLA; Department of Hematology, The Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China
| | - Hao-Min Zhang
- Department of Hematology, The Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China
| | - Di Lu
- Medical School of Chinese PLA; The Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China
| | - Zi-Ning Wang
- Medical School of Chinese PLA; Department of Hematology, The Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China
| | - Hao-Ran Chen
- School of Management, Shanxi Medical University, Taiyuan 030604, Shanxi Province, China
| | - Xue-Chun Lu
- Department of Hematology, The Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China. E-mail:
| |
Collapse
|
6
|
Xu X, Wang JJ, Jiang JJ, Zhang T, Lv XF, Wang SQ, Liu ZJ, Li WD, Lu XC. Mass drug administration in response to vivax malaria resurgence in Anhui Province of Huanghuai Plain, China. Adv Parasitol 2022; 116:115-152. [PMID: 35752446 DOI: 10.1016/bs.apar.2022.04.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
This article summarizes the background, specific conditions, main measures, steps and effects of the implementation of Mass Drug Administration (MDA) to control the local P. vivax malaria epidemic in Anhui Province in central China. Distributing medicines to the designated population quickly controlled the local epidemic of P. vivax. Implementing MDA to control P. vivax ensured the correct selection of medicines, clarification of the targeted population for receipt of medicines, and assurance of a high rate of compliance through government support and health education. These results provide a reference for countries and regions experiencing similar events and planning to implement MDA in malaria control.
Collapse
Affiliation(s)
- Xian Xu
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China
| | - Jian-Jun Wang
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China
| | - Jing-Jing Jiang
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China
| | - Tao Zhang
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China
| | - Xiao-Feng Lv
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China
| | - Shu-Qi Wang
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China
| | - Zi-Jian Liu
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China
| | - Wei-Dong Li
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China.
| | - Xue-Chun Lu
- Anhui Provincial Center for Disease Control and Prevention, Anhui, PR China
| |
Collapse
|
7
|
Ge FL, Si LL, Yang Y, Li YH, Lv ZL, Liu WH, Liao H, Wang J, Zou J, Li L, Li H, Zhang ZL, Wang JB, Lu XC, Xu DP, Bai ZF, Liu Y, Xiao XH. Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model. Front Pharmacol 2021; 12:756975. [PMID: 34776974 PMCID: PMC8578813 DOI: 10.3389/fphar.2021.756975] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Accepted: 10/06/2021] [Indexed: 01/15/2023] Open
Abstract
Liuweiwuling Tablet (LWWL) is a licensed Chinese patent medicine (approval number: Z20060238) included in the national health insurance for anti-inflammation of chronic HBV infection, whereas its anti-HBV effect remains clarification. The study aimed to clarify its antiviral effect and related mechanisms. HepG2.2.15 cells (wild-type HBV-replicating cells) and HepG2. A64 cells (entecavir-resistant HBV-replicating cells) were used for in vitro test. Hydrodynamic injection-mediated HBV-replicating mouse model was used for in vivo test. Active compounds and related mechanisms for antiviral effect of LWWL were analyzed using network pharmacology and transcriptomics. The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg-1 d-1 for 4 weeks)-treated mice had 1.16 log10 IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. Compared to tenofovir control, LWWL was less effective in suppressing HBV DNA but more effective in suppressing HBV antigens. Thirteen differentially-expressed genes were found in relation to HBV-host interaction and some of them were enriched in interferon (IFN)-β pathway in LWWL-treated HepG2.2.15 cells. CD3+CD4+ T-cell frequency and serum IFN-γ were significantly increased in LWWL-treated mice compared to LWWL-untreated mice. Among 26 compounds with potential anti-HBV effects that were predicted by network pharmacology, four compounds (quercetin, luteolin, wogonin, and kaempferol) were experimentally confirmed to have antiviral potency. In conclusion, LWWL had potent inhibitory effect on both wild-type and entecavir-resistant HBV, which might be associated with increasing IFN-β and IFN-γ production.
Collapse
Affiliation(s)
- Fei-Lin Ge
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.,Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Lan-Lan Si
- Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Yan Yang
- Department of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Yuan-Hua Li
- Department of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Zhong-Lin Lv
- Department of Hematology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China
| | - Wen-Hui Liu
- Department of Gastroenterology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China
| | - Hao Liao
- Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Jun Wang
- Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Jun Zou
- Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Le Li
- Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Hui Li
- Department of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Zi-Lin Zhang
- Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Jia-Bo Wang
- Department of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Xue-Chun Lu
- Department of Hematology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China
| | - Dong-Ping Xu
- Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Zhao-Fang Bai
- Department of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Yan Liu
- Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Xiao-He Xiao
- Department of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| |
Collapse
|
8
|
Su Q, Li T, He PF, Lu XC, Yu Q, Gao QC, Wang ZJ, Wu MN, Yang D, Qi JS. Trichostatin A ameliorates Alzheimer's disease-related pathology and cognitive deficits by increasing albumin expression and Aβ clearance in APP/PS1 mice. Alzheimers Res Ther 2021; 13:7. [PMID: 33397436 PMCID: PMC7784383 DOI: 10.1186/s13195-020-00746-8] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Accepted: 12/08/2020] [Indexed: 02/08/2023]
Abstract
BACKGROUND Alzheimer's disease (AD) is an intractable neurodegenerative disorder in the elderly population, currently lacking a cure. Trichostatin A (TSA), a histone deacetylase inhibitor, showed some neuroprotective roles, but its pathology-improvement effects in AD are still uncertain, and the underlying mechanisms remain to be elucidated. The present study aims to examine the anti-AD effects of TSA, particularly investigating its underlying cellular and molecular mechanisms. METHODS Novel object recognition and Morris water maze tests were used to evaluate the memory-ameliorating effects of TSA in APP/PS1 transgenic mice. Immunofluorescence, Western blotting, Simoa assay, and transmission electron microscopy were utilized to examine the pathology-improvement effects of TSA. Microglial activity was assessed by Western blotting and transwell migration assay. Protein-protein interactions were analyzed by co-immunoprecipitation and LC-MS/MS. RESULTS TSA treatment not only reduced amyloid β (Aβ) plaques and soluble Aβ oligomers in the brain, but also effectively improved learning and memory behaviors of APP/PS1 mice. In vitro study suggested that the improvement of Aβ pathology by TSA was attributed to the enhancement of Aβ clearance, mainly by the phagocytosis of microglia, and the endocytosis and transport of microvascular endothelial cells. Notably, a meaningful discovery in the study was that TSA dramatically upregulated the expression level of albumin in cell culture, by which TSA inhibited Aβ aggregation and promoted the phagocytosis of Aβ oligomers. CONCLUSIONS These findings provide a new insight into the pathogenesis of AD and suggest TSA as a novel promising candidate for the AD treatment.
Collapse
Affiliation(s)
- Qiang Su
- Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China
| | - Tian Li
- Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China
| | - Pei-Feng He
- Institute of Medical Data Sciences and School of Management, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
| | - Xue-Chun Lu
- Department of Hematology, the Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, China.
| | - Qi Yu
- Institute of Medical Data Sciences and School of Management, Shanxi Medical University, Taiyuan, 030001, Shanxi, China
| | - Qi-Chao Gao
- Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China
| | - Zhao-Jun Wang
- Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China
| | - Mei-Na Wu
- Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China
| | - Dan Yang
- Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China
| | - Jin-Shun Qi
- Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
| |
Collapse
|
9
|
Chen XM, Cao F, Zhang HM, Chen HR, Zhang JD, Zhi P, Li ZY, Wang YX, Lu XC. [Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:587-592. [PMID: 32228827 DOI: 10.3760/cma.j.cn112148-20200308-00172] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: Present study investigated the mechanism of heart failure associated with coronavirus infection and predicted potential effective therapeutic drugs against heart failure associated with coronavirus infection. Methods: Coronavirus and heart failure were searched in the Gene Expression Omnibus (GEO) and omics data were selected to meet experimental requirements. Differentially expressed genes were analyzed using the Limma package in R language to screen for differentially expressed genes. The two sets of differential genes were introduced into the R language cluster Profiler package for gene ontology (GO) and Kyoto gene and genome encyclopedia (KEGG) pathway enrichment analysis. Two sets of intersections were taken. A protein interaction network was constructed for all differentially expressed genes using STRING database and core genes were screened. Finally, the apparently accurate treatment prediction platform (EpiMed) independently developed by the team was used to predict the therapeutic drug. Results: The GSE59185 coronavirus data set was searched and screened in the GEO database, and divided into wt group, ΔE group, Δ3 group, Δ5 group according to different subtypes, and compared with control group. After the difference analysis, 191 up-regulated genes and 18 down-regulated genes were defined. The GEO126062 heart failure data set was retrieved and screened from the GEO database. A total of 495 differentially expressed genes were screened, of which 165 were up-regulated and 330 were down-regulated. Correlation analysis of differentially expressed genes between coronavirus and heart failure was performed. After cross processing, there were 20 GO entries, which were mainly enriched in virus response, virus defense response, type Ⅰ interferon response, γ interferon regulation, innate immune response regulation, negative regulation of virus life cycle, replication regulation of viral genome, etc. There were 5 KEGG pathways, mainly interacting with tumor necrosis factor (TNF) signaling pathway, interleukin (IL)-17 signaling pathway, cytokine and receptor interaction, Toll-like receptor signaling pathway, human giant cells viral infection related. All differentially expressed genes were introduced into the STRING online analysis website for protein interaction network analysis, and core genes such as signal transducer and activator of transcription 3, IL-10, IL17, TNF, interferon regulatory factor 9, 2'-5'-oligoadenylate synthetase 1, mitogen-activated protein kinase 3, radical s-adenosyl methionine domain containing 2, c-x-c motif chemokine ligand 10, caspase 3 and other genes were screened. The drugs predicted by EpiMed's apparent precision treatment prediction platform for disease-drug association analysis were mainly TNF-α inhibitors, resveratrol, ritonavir, paeony, retinoic acid, forsythia, and houttuynia cordata. Conclusions: The abnormal activation of multiple inflammatory pathways may be the cause of heart failure in patients after coronavirus infection. Resveratrol, ritonavir, retinoic acid, amaranth, forsythia, houttuynia may have therapeutic effects. Future basic and clinical research is warranted to validate present results and hypothesis.
Collapse
Affiliation(s)
- X M Chen
- National Medical Center for Geriatric Diseases, Department of Hematology, Second Medical Center, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - F Cao
- National Medical Center for Geriatric Diseases, Second Medical Center, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - H M Zhang
- National Medical Center for Geriatric Diseases, Department of Hematology, Second Medical Center, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - H R Chen
- School of Management, Shanxi Medical University, Taiyuan 030001, China
| | - J D Zhang
- Graduate School of Medical College of Chinese People's Liberation Army, Beijing 100853, China
| | - P Zhi
- School of Management, Shanxi Medical University, Taiyuan 030001, China
| | - Z Y Li
- School of Management, Shanxi Medical University, Taiyuan 030001, China
| | - Y X Wang
- Department of Traditional Chinese Medicine, Dongfang Hospital Affiliated to Tongji University, Shanghai 200120, China
| | - X C Lu
- National Medical Center for Geriatric Diseases, Department of Hematology, Second Medical Center, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| |
Collapse
|
10
|
Liu DD, Cao XB, Li HL, Lu XC, Shou BQ, Lei MT, Wang CH, Xue H. [Effect of comprehensive AIDS intervention among men aged 50 or over who had non-marital sexual behavior]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 40:1595-1600. [PMID: 32062922 DOI: 10.3760/cma.j.issn.0254-6450.2019.12.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the effectiveness of AIDS intervention programs on men aged 50 or over and having had non-marital sexual behavior. Methods: A community-based intervention/experimental and based on individual level study was adopted. Stratified sampling method was used. 12 townships/streets in Fuyang district of Hangzhou were identified as intervention or control group (six research sites each). All of the subjects in the township (street) were included. The inclusion criteria of study objects would include men aged 50 or older who reported having unmarried sex in the last year. Estimated sample size was 290, with each 145 in the intervention group and the control group. All the intervention group participants were provided with a total of 4 intervention-related items (knowledge and education on AIDS prevention, information radiation and behavioral change, broadcast expert lectures), every 3 months, for 12 month, the main evaluation indicators would include: incidence of non-marital sex and commercial sex in the last year, condom use when having non-marital sex in the last episode. Results: A total of 312 subjects were recruited. 300 of them completed the baseline study while 284 of them completed the follow-up survey. Among the subjects who had undergone the baseline study, the average age was (65.58±7.89), 71.33% were married or cohabiting with someone, 52.00% having had primary school education. After the implementation of intervention programs, the incidence of non-marital sex dropped to 59.42% (82/138) and the incidence of commercial sex dropped from 79.73% (118/148) to 55.07% (76/138). Condom use rate in the last non-marital sexual contact increased from 19.59% (29/148) to 51.22% (42/82). In the control group, the incidence of non-marital sex in the year before dropped to 74.66% (109/146) and the incidence of commercial sex dropped from 91.45% (139/152) to 72.60% (106/146). Rates of condom use during the last non-marital sexual contact dropped from 32.89% (50/152) to 31.19% (34/109). Statistically, there were significant differences appeared between the two groups on the incidence of non-marital sex in the past year (χ(2)=7.48, P=0.008), the incidence of commercial sex in the last year (χ(2)=9.47, P=0.003) and the rate of condom use in the last sex experience (χ(2)=7.83, P=0.007). Conclusions: Results from this intervention study showed that: in the intervention group, both the incidence rates of non-marital or commercial sex had reduced, together with the increase of condom use in non-marital sex in the last sexual experience. Intervention strategies that involving knowledge and education on AIDS prevention, information radiation and behavioral change, broadcasting lectures by experts etc. were all proved effective.
Collapse
Affiliation(s)
- D D Liu
- National Center for STD/AIDS Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 102206, China; Fuyang District Center for Disease Control and Prevention of Hangzhou, Hangzhou 311400, China
| | - X B Cao
- National Center for STD/AIDS Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - H L Li
- Fuyang District Center for Disease Control and Prevention of Hangzhou, Hangzhou 311400, China
| | - X C Lu
- Fuyang District Center for Disease Control and Prevention of Hangzhou, Hangzhou 311400, China
| | - B Q Shou
- Fuyang District Center for Disease Control and Prevention of Hangzhou, Hangzhou 311400, China
| | - M T Lei
- Fuyang District Center for Disease Control and Prevention of Hangzhou, Hangzhou 311400, China
| | - C H Wang
- Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - H Xue
- Beijing Lanchengyouning Health Management Limited Company, Beijing 100022, China
| |
Collapse
|
11
|
Niu HQ, Li ZH, Zhao WP, Zhao XC, Zhang C, Luo J, Lu XC, Gao C, Wang CH, Li XF. Sirolimus selectively increases circulating Treg cell numbers and restores the Th17/Treg balance in rheumatoid arthritis patients with low disease activity or in DAS28 remission who previously received conventional disease-modifying anti-rheumatic drugs. Clin Exp Rheumatol 2020; 38:58-66. [PMID: 31074719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2018] [Accepted: 03/05/2019] [Indexed: 06/09/2023]
Abstract
OBJECTIVES Regulatory T (Treg) cells are crucial players in the prevention of autoimmunity. Mechanistic target of rapamycin (mTOR) signalling negatively controls the development and function of Treg cells. The aim of the present study was to evaluate the effects of rapamycin, under the generic name sirolimus, on CD4+CD25+FoxP3+ Treg cells in rheumatoid arthritis (RA) patients with low disease activity or in DAS28 remission. METHODS Fifty-five RA patients and 60 healthy controls were enrolled in this study. All patients had previously received conventional disease-modifying anti-rheumatic drugs (DMARDs) and were considered to have a low DAS28 score (≤3.2). Peripheral blood samples and clinical information were obtained at baseline and following 6 and 12 weeks of sirolimus treatment, or after 12 weeks of conventional treatment. Peripheral blood samples were also obtained from the healthy controls. The circulating levels of lymphocyte subpopulations were assessed by flow cytometry. RESULTS Thirty-five patients received sirolimus and 20 patients continued treatment with conventional DMARDs. The absolute counts and proportions of CD4+CD25+FoxP3+ Treg cells were significantly lower in all RA patients with DAS28 ≤ 3.2 as compared with those in healthy controls. By contrast, the difference in circulating Th17 cell numbers was not significant. Sirolimus administration resulted in elevations in circulating Treg cell numbers and significant reductions in the Th17/Treg cell ratio, whereas the circulating level of Treg cells and the Th17/Treg cell ratio in patients under conventional treatment both showed a tendency of reduction. Furthermore, a greater proportion of patients under sirolimus treatment achieved DAS28-based remission at 12 weeks. CONCLUSIONS Sirolimus can favourably expand Treg cells in RA patients with DAS28 ≤3.2, consequently restoring a healthy balance of Th17/Treg cells, which might improve the likelihood of long-term and sustained clinical remission and reduce the probability of disease flare-ups in RA.
Collapse
Affiliation(s)
- Hong-Qing Niu
- Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Zhao-Hua Li
- Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Wen-Peng Zhao
- Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Xiang-Cong Zhao
- Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Chen Zhang
- Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Jing Luo
- Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Xue-Chun Lu
- Department of Geriatric Haematology, Chinese PLA General Hospital, Beijing, China
| | - Chong Gao
- Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA
| | - Cai-Hong Wang
- Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
| | - Xiao-Feng Li
- Department of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China
| |
Collapse
|
12
|
Zhang F, Yang B, Zhang K, Hou ML, Lu XC, Li YX. CCND1-BCL2 Gene Network: A direct target of Amifostine in human acute megakaryocytic leukemia cells. Chem Biol Drug Des 2017; 89:681-693. [PMID: 27762064 DOI: 10.1111/cbdd.12889] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2016] [Revised: 08/19/2016] [Accepted: 09/23/2016] [Indexed: 11/30/2022]
Abstract
Amifostine, 2-(3-aminopropyl) aminoethyl phosphorothioate, is a broad-spectrum cytoprotective agent used to treat nuclear radiation and chemical weapon injuries. Recently, amifostine has been shown to have a profound biological influence on tumor cells. To examine the effects and mechanisms underlying the effects of amifostine on human acute megakaryocytic leukemia, we evaluated the efficacy of amifostine against Dami cells and observed a cell cycle arrest in G2 /M phase. Amifostine treatment also induced cell apoptosis of Dami cells which corresponds to formal studies. Through whole-genome microarray and bioinformatics analyses, we found that amifostine affected the gene expression of CCND1, BCL2, and CASP3 which revealed the mechanism amifostine acted on Dami cells. Thus, CCND1-BCL2 Gene Network is predicted to be a direct target of amifostine treating human acute megakaryocytic leukemia, which may provide a novel potential target for the therapy of several subtypes of human AML.
Collapse
Affiliation(s)
- Feng Zhang
- National Engineering Laboratory for Drug gable Gene and Protein Screening, Northeast Normal University, Changchun, Jilin, China.,Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China
| | - Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
| | - Kailiang Zhang
- Schools of Stomatology, Lanzhou University, Lanzhou, China
| | - Mei-Ling Hou
- National Engineering Laboratory for Drug gable Gene and Protein Screening, Northeast Normal University, Changchun, Jilin, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
| | - Yu-Xin Li
- National Engineering Laboratory for Drug gable Gene and Protein Screening, Northeast Normal University, Changchun, Jilin, China
| |
Collapse
|
13
|
Wang HT, Yang B, Hu B, Chi XH, Luo LL, Yang HQ, Lang XL, Geng J, Qiao CX, Li Y, Wu XX, Zhu HL, Lv M, Lu XC. The effect of amifostine on differentiation of the human megakaryoblastic Dami cell line. Cancer Med 2016; 5:2012-21. [PMID: 27228575 PMCID: PMC4884634 DOI: 10.1002/cam4.759] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2015] [Revised: 04/01/2016] [Accepted: 04/06/2016] [Indexed: 01/09/2023] Open
Abstract
Amifostine is a cytoprotective drug that was initially used to control and treat nuclear radiation injury and is currently used to provide organ protection in cancer patients receiving chemotherapy. Clinical studies have also found that amifostine has some efficacy in the treatment of cytopenia caused by conditions such as myelodysplastic syndrome and immune thrombocytopenia, both of which involve megakaryocyte maturation defects. We hypothesized that amifostine induced the differentiation of megakaryocytes and investigated this by exposing the human Dami megakaryocyte leukemia cell line to amifostine (1 mmol/L). After 12 days of amifostine exposure, optical microscopy showed that the proportion of Dami cells with diameters >20 μm had increased to 24.63%. Transmission electron microscopy identified the development of a platelet demarcation membrane system, while flow cytometry detected increased CD41a expression and decreased CD33 expression on the Dami cell surface. Ploidy analysis found that the number of polyploid cells with >4N DNA content increased to 27.96%. We did not detect any elevation in the mRNA or protein levels of megakaryocytic differentiation-associated transcription factors GATA-binding factor 1 (GATA-1) and nuclear factor, erythroid 2 (NF-E2), but nuclear import assay revealed an increased nuclear translocation of these proteins. These findings indicate that amifostine induced the differentiation of Dami cells into mature megakaryocytes via a mechanism involving increased nuclear translocation of the transcription factors, NF-E2 and GATA-1.
Collapse
Affiliation(s)
- Hai-Tao Wang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, 100853, China.,Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, 100039, China.,Department of Hematology, First Affiliated Hospital of Chinese PLA General Hospital, Beijing, 100048, China
| | - Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, 100853, China
| | - Bo Hu
- Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, 100039, China.,Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, 100142, China
| | - Xiao-Hua Chi
- Department of Pharmacy, Chinese PLA Rocket General Hospital, Beijing, 100800, China
| | - Long-Long Luo
- Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, 100039, China
| | - Hong-Qi Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, 100853, China
| | - Xiao-Ling Lang
- Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, 100039, China
| | - Jing Geng
- Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, 100039, China
| | - Chun-Xia Qiao
- Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, 100039, China
| | - Yan Li
- Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, 100039, China
| | - Xiao-Xiong Wu
- Department of Hematology, First Affiliated Hospital of Chinese PLA General Hospital, Beijing, 100048, China
| | - Hong-Li Zhu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, 100853, China
| | - Ming Lv
- Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, 100039, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, 100853, China
| |
Collapse
|
14
|
Xin LJ, Yang B, Lu XC, Yin P, Tian Y, Zhu HL. [Prognostic and Therapeutic Significance of Molecular Subtyping on Aged Patient with Advanced Diffuse Large B Cell Lymphoma---A Case Report]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2016; 24:457-62. [PMID: 27151010 DOI: 10.7534/j.issn.1009-2137.2016.02.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To analyze the clinical course of a very elderly patient with advanced diffuse large B cell lymphoma (DLBCL), so as to explore the incidence, prognosis and treatment of DLBCL and to analyse the prognostic and therapeutic significance of molecular subtype. METHODS The clinical history, auxiliary examinations, clinical diagnostic standards, therapeutic methods, biopsy and autopsy of this patient were retrospectively analyzed; the incidence, current treatment status, molecular biological features, and prognostic and therapeutic significance of molecular subtype were studied. RESULTS After admission, this patient was diagnosed as non-GCB DLBCL, NOS, stage IV B and in the high risk group (IPI = 5, ECOG = 2). She achieved a decent partial response after many times of imunochemotherapy, but his disease status soon progressed. The liver occupying biopsy revealed non-GCB, while the spleen tumor pathology revealed GCB; pathological typing of these two methods was completely opposite. Autopsy pathological diagnosis showed that the death causes included extensive tumor metastasis, dyscrasia and respiratory circle failure. CONCLUSION Incidence of aged patients with DLBCL is high, and the disease is aggressive; the treatment is low responsive and difficult, and new therapeutic methods are needed. Gene expression profile (GEP) can provide molecular subtype and potential pathogenic mechanism, which can promote the development of new targeted therapy and individualized treatment.
Collapse
Affiliation(s)
- Li-Jun Xin
- Department of Geriatric Hematology, General Hospital of Chinese PLA, Medical School of Chinese PLA, Beijing 100853, China
| | - Bo Yang
- Department of Geriatric Hematology, General Hospital of Chinese PLA, Medical School of Chinese PLA, Beijing 100853, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, General Hospital of Chinese PLA, Medical School of Chinese PLA, Beijing 100853, China
| | - Peng Yin
- The First Clinic, Administration Burean of the General Logistics Department, Chinese PLA, Beijing 100842, China
| | - Ye Tian
- The First Clinic, Administration Burean of the General Logistics Department, Chinese PLA, Beijing 100842, China
| | - Hong-Li Zhu
- Department of Geriatric Hematology, General Hospital of Chinese PLA, Medical School of Chinese PLA, Beijing 100853, China. E-mail:
| |
Collapse
|
15
|
Liu Y, Zhong WW, Kang HY, Wang LL, Lu XC, Yu L, Zhu HL. [Clinical significance of ID4 methylation detection by quantitative methylation-specific PCR in acute leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2014; 22:675-80. [PMID: 24989275 DOI: 10.7534/j.issn.1009-2137.2014.03.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The advances of treatment improved the prognosis of the patients with acute leukemia (AL) in the last decade, but the lack of general biomarker for predicting relapse in AL, which is one of the most important factors influencing the survival and prognosis. DNA methylation of ID4 gene promoter occurred frequently in patients with AL and was found to be highly related to the tumor progression. Based on the previous work of the setup of methylation-specific quantitative PCR system for ID4 gene, this study was designed to investigate the relation between the quantitative indicator of methylation density, percentage of methylation reference(PMR) value, and different disease status of AL. PMR of ID4 was detected by MS-PCR in bone marrow (BM) samples of 17 healthy persons and 54 AL patients in the status of newly diagnosis, complete remission and disease relapse. The results showed that at different disease status, PMR value in newly diagnosed group was significantly lower than that in complete remission group (P = 0.031). Among serial samples, PMR value remained very low at the status of patients with continuous complete remission (<1.5‰), and increased along with the accumulation of tumor cells at relapse. In 1 relapse case, the abnormal rise of PMR value occurred prior to morphological relapse. PMR value seemed to be related to body tumor cell load. It is concluded that the quantitative indicator of methylation density and PMR value may reflect the change of tumor cell load in acute leukemia patients. Dynamic monitoring of PMR maybe predict leukemia relapse.
Collapse
Affiliation(s)
- Yang Liu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Wen-Wen Zhong
- Department of Geriatric Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
| | - Hui-Yuan Kang
- Clinical Laboratory, Chinese PLA General Hospital, Beijing 100853, China
| | - Li-Li Wang
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Li Yu
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China. E-mail:
| | - Hong-Li Zhu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China. E-mail:
| |
Collapse
|
16
|
Yan G, Zhong P, Fan L, Lu XC, Pei J, Meng XY. GW25-e5249 The drug interaction of clopidogrel carboxylic acid and atorvastatin: A study based on bioinformatic analysis. J Am Coll Cardiol 2014. [DOI: 10.1016/j.jacc.2014.06.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
17
|
Liu Y, Kang HY, Wang LL, Lu XC, Zhu HL, Yu L. [Establishment of methylation-specific quantitative PCR system for ID4 gene in acute leukemia cells and its specificity and sensitivity]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2014; 22:269-74. [PMID: 24762990 DOI: 10.7534/j.issn.1009-2137.2014.02.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
DNA methylation of ID4 gene promoter occurred frequently in patients with acute leukemia and was found to be highly related to the tumor progression. Due to lack of the appropriate methylation detection methods, the relation between the quantification of ID4 methylation and the states of acute leukemia is still unclear. This study purposed to set up a methylation-specific quantitative PCR system for ID4 and investigate the specificity and sensitivity of this methylation detection. The plasmids combined with target gene as well as with internal reference were constructed, and the standard curves were set up by using above mentioned plasmids. The specificity of this detection system in cell lines was verified through techniques of MSP and quantitative MSP. The sensitivity of this detection system was verified by mixing methylation-positive and negative cell lines in varying proportions and through amplification of qualitative MSP. The results showed that the standard curves were establish successfully. The results of quantitative MS-PCR in cell lines were consistent with those of MS-PCR, and as low as 1: 10(-5) of ID4 methylation positive cells could be detected by the new methylation detection assay. In newly diagnosed acute leukemia patients, the positive rate of quantitative MSP was higher. It is concluded that a complete quantitative MSP system for ID4 methylation detection has been established and this quantitative MSP method has good specificity and high sensitivity.
Collapse
Affiliation(s)
- Yang Liu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Hui-Yuan Kang
- Clinical Laboratory, Chinese PLA General Hospital, Beijing 100853, China
| | - Li-Li Wang
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Hong-Li Zhu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China. E-mail:
| | - Li Yu
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China. E-mail:
| |
Collapse
|
18
|
Yang B, Wang J, Cai LL, Zhu HL, Yu RL, Chi XH, Lu XC. Treatment of multiple solitary plasmacytomas with cytokine-induced killer cells. Cytotherapy 2014; 16:278-84. [PMID: 24438905 DOI: 10.1016/j.jcyt.2013.11.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2013] [Revised: 10/31/2013] [Accepted: 11/02/2013] [Indexed: 11/17/2022]
Abstract
BACKGROUND AIMS Currently available treatment methods for advanced plasmacytoma include surgery, chemotherapy, radiotherapy, immunomodulatory agents, hematopoietic stem cell transplantation and donor lymphocyte infusion. We report a case of advanced refractory multiple solitary plasmacytomas in a 68-year-old Asian man with multiple bone lesions, in whom autologous cytokine-induced killer (CIK) cells were administered in an effort to eliminate residual tumor lesions. METHODS CIK cells were infused monthly for 21 courses. RESULTS The patient has survived 63 months since the first hospital visit without disease progression for 40 months. CONCLUSIONS This case represents the first report of autologous CIK cell immunotherapy used successfully to suppress multiple solitary plasmacytomas and resolve bone lesions.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
| | - Ji Wang
- Department of Cadre Health Care, Chinese PLA Navy General Hospital, Beijing, China
| | - Li-Li Cai
- Department of Geriatric Laboratory Medicine, Chinese PLA General Hospital, Beijing, China
| | - Hong-Li Zhu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
| | - Rui-Li Yu
- Institute of Otorhinolaryngology, Chinese PLA General Hospital, Beijing, China
| | - Xiao-Hua Chi
- Department of Pharmacy, the Second Artillery General Hospital, Beijing, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China.
| |
Collapse
|
19
|
Yang Y, Yang B, Cai LL, Ran HH, Yu RL, Chi XH, Zhu HL, Li SX, Liu Y, Wang Y, Han WD, Yao SQ, Lu XC. [Clinical study of autologous cytokine induced killer cells combined with chemotherapy for elderly patients with acute myeloid leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2014; 22:58-63. [PMID: 24598652 DOI: 10.7534/j.issn.1009-2137.2014.01.013] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
This study was purposed to evaluate the effectiveness and safety of autologous cytokine induced killer (CIK) cells combined with chemotherapy in treatment of elderly patients with acute myeloid leukemia. Peripheral blood mononuclear cells (PBMNC) were isolated from 5 elderly patients with acute myeloid leukemia, and then augmented by priming with interferon gamma (IFN-γ) followed by IL-2 and monoclonal antibody (mAb) against CD3. The autologous CIK cells thus obtained were infused back to individual patients, 28 days as one cycle. The changes in cellular immune function, incidence of infection, independence of hematoglobin or blood transfusion, and progression of disease were observed and assessed before and after therapy. The results showed that the 46 cycles of CIK cell infusion were performed for 5 patients, no adverse reaction was observed in these patients. The percentages of CD3(+), CD3(+)CD8(+) and CD3(+)CD56(+) increased significantly (P < 0.05), The therapy of CIK could significantly reduce the incidence of infection (P < 0.05) and shorten the time of high fever in AML patients (P < 0.05). CIK also could reduce the volume of erythrocyte infusion to maintenance hematoglobin level (P < 0.05). We found that although CIK could not change the outcome of AML, the combination of CIK and chemotherapy could control patients' condition and prolong their survival during the development and end stage of AML. It is concluded that autologous CIK cells combined with chemotherapy is safe and efficacious for the elderly patients with acute myeloid leukemia.
Collapse
Affiliation(s)
- Yang Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Li-Li Cai
- Department of Geriatric Laboratorial Medicine, Chinese PLA General Hospital, Beijing 100853, China
| | - Hai-Hong Ran
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Rui-Li Yu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Xiao-Hua Chi
- Department of Pharmacy, The Second Artillery General Hospital, Beijing 100800, China
| | - Hong-Li Zhu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Su-Xia Li
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Yang Liu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Yao Wang
- Department of Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, Beijing 100853, China
| | - Wei-Dong Han
- Department of Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, Beijing 100853, China
| | - Shan-Qian Yao
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| |
Collapse
|
20
|
Liu Y, Bao EN, Zhong WW, Lu XC, Zhu HL. [Efficacy and safety analysis of interferon combined with imatinib in treating chronic myeloid leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2014; 22:304-9. [PMID: 24762996 DOI: 10.7534/j.issn.1009-2137.2014.02.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Imatinib has been recognized as the frontline therapy drug in chronic myeloid leukemia (CML), however, only limited patients could achieve complete molecular remission (CMR). Recent clinical and basic proofs indicated an improved treatment outcome by the combination of interferon and Imatinib. This study was purposed to evaluated systematically the efficacy and safety of interferon plus Imatinib in patients with CML. Data from relative clinical trials were from clinical trial of gov and Cochrane Collaboration. A comprehensive literature search was performed from data bases such as pubMed and EM. The results indicated that 7 clinical trials and 12 research papers met the criteria enrolled in study, included 697 cases in total. The combination group had higher complete cytogenetic remission (CCgR) rate than imatinib alone at 6 months (58% vs 42%; P = 0.0001) and 12 months (74% vs 68%; P = 0.004). The major molecular remission (MMR) rate was also higher in the combination group at 6 months (58% vs 34%; P = 0.0001) and 12 months (66% vs 47%; P < 0.0001). Furthermore, compared with single drug, the combination group had superior CMR rate at 6 months (13% vs 2%; P = 0.0002) and 12 months (14% vs 5%; P = 0.0009). The major adverse effects of combination therapy were rash, asthenia, edema and musculoskeletal events, and combination therapy was more prone to inducing neutropenia, thrombocytopenia and mild anemia. It is concluded that compared with Imatinib alone, the combination of interferon and Imatinib has better clinical efficacy in treating CML with earlier cytogenetic and molecular remission. It is also a safe therapy in spite of slightly weaker tolerance than single drug therapy.
Collapse
Affiliation(s)
- Yang Liu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Er-Ning Bao
- Department of Medical Record Quality Management, Chinese PLA General Hospital, Beijing 100853, China
| | - Wen-Wen Zhong
- Department of Geriatric Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Hong-Li Zhu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| |
Collapse
|
21
|
Wang HT, Yang B, Cai LL, Ran HH, Zhang WY, Zhu HL, Yang Y, Li SX, Fan H, Chi XH, Yu RL, Zhang F, Li BL, Lin J, Zhai B, Yao SQ, Lu XC. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013; 21:1464-70. [PMID: 24370030 DOI: 10.7534/j.issn.1009-2137.2013.06.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The purpose of this study was to explore the clinicopathological features, therapy and prognostic factors of elderly patients with non-Hodgkin's lymphoma (NHL). The clinical data including general clinical characteristics, pathological features, chemotherapy selection and treatment response of 30 patients with NHL in our hospital from January 2003 to December 2012 were analyzed retrospectively. The survival was analyzed by using Kaplan-Meier methods, and the prognosis was evaluated by COX regression multivariate analysis model. The clinical parameters selected include age, Ann Arbor stage, international prognostic index (IPI), B symptom and lactate dehydrogenase (LDH) levels. The results showed that all the patients suffered from underlying disease, and the cardiovascular disease (hypertension, coronary heart disease, arrhythmia) is the most common, and minority (8/30) combined with secondary tumor, the 63% (19/30) cases had B symptoms at diagnosis. only 2 cases were diagnosed as T-cell lymphoma; the 93% (28/30) cases combined with B-cell lymphoma, 57% (17/28) of them combined with diffuse large B-cell lymphoma. Ann-Arbor stage ≤ IIwas 37% (11/30);10(37%) patient's IPI score was ≤ 2, and 67% (20/30) was scored 3-5; 13(43%) patient's serum LDH level was abnormal. Modified R-CHOP chemotherapy was given individually on the basis of clinical features. The patients achieved complete remission, partial remission, stable disease, or progressive disease accounted for 14 (46.7%), 13 (43.3%), 1 (3.3%), and 2 (6.7%), respectively; the total reaction rate was 90% after 4 cycles of chemotherapy; the overall survival (OS) rate at 1 and 2 years was 73.3% and 43.3%, and progression-free survival (PFS)rate at 0.5 and 1 years was 62.2% and 54.9%; multivariate analysis by COX regression showed that B symptoms and Ann-Arbor stage were independent factors (P = 0.014, 0.039; RR = 6.678, 4.939, respectively) affecting the OS of elderly NHL, and IPI score affected PFS independently. It is concluded that elderly patients with NHL usually are of late stage at newly diagnosis and have suffered from underlaying diseases. Besides strengthening supportive treatment, modified R-CHOP chemotherapy should be given individually according to different prognosis. B symptoms and Ann-Arbor stage >II are indicators for poor prognosis of elderly NHL.
Collapse
Affiliation(s)
- Hai-Tao Wang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Li-Li Cai
- Department of Geriatric Laboratorial Medicine, Chinese PLA General Hospital, Beijing 100853, China
| | - Hai-Hong Ran
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Wen-Ying Zhang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Hong-Li Zhu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Yang Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Su-Xia Li
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Hui Fan
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Xiao-Hua Chi
- Department of Pharmacy, The Second Artillery General Hospital, Beijing 100800, China
| | - Rui-Li Yu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Feng Zhang
- Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, China
| | - Bao-Ling Li
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Jie Lin
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Bing Zhai
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Shan-Qian Yao
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China. E-mail:
| |
Collapse
|
22
|
Chang C, Yang B, Zhang L, Zhu HL, Lu XC, Guo B, Cai LL, Han WD, Wang Y, Fan H, Li SX, Liu Y, Yang Y, Zhai B, Ran HH, Lin J, Zhang F. [Curative effect of decitabine combined with cytokine-induced killer cells in two elderly patients with acute myeloid leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013; 21:62-7. [PMID: 23484693 DOI: 10.7534/j.issn.1009-2137.2013.01.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
This study was aimed to evaluate the effectiveness and safety of low methylation drug decitabine combined with autologous cytokine induced killer cells (CIK) to treat the elderly patients with acute myeloid leukemia (AML). Two AML patients aged over 80 years old were diagnosed and treated in our department from 2006 to 2012; both company with MDS history, and one case was M4-type, another case was M6-type according to FAB classification. The changes in lymphocyte subsets, hematologic response, transfusion frequency, leukemic gene expression, obtaining CR or PR, quality of life and survival time of the patients with different treatment regimen (decitabine alone; CIK alone; decitabine combined with CIK) were systematically observed. The results showed that therapy of decitabine combined with CIK cells could reduce bone marrow suppression extent, decrease the frequency and volume of blood transfusion, and prolong the duration of partial remission, compared with the single use of CIK cell infusion and single use of decitabine treatment. Meanwhile, the kinds of expressed genes associated with leukemia decreased and the survival time was prolonged obviously. The patients' life quality significantly improved. It is concluded that decitabine combined with CIK for treatment of elderly patients with AML is safe and effective.
Collapse
Affiliation(s)
- Cheng Chang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Wang X, Du Y, Fan L, Ye P, Yuan Y, Lu X, Wang F, Zeng Q. Relationships between HDL-C, hs-CRP, with central arterial stiffness in apparently healthy people undergoing a general health examination. PLoS One 2013; 8:e81778. [PMID: 24312587 PMCID: PMC3849294 DOI: 10.1371/journal.pone.0081778] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2013] [Accepted: 10/16/2013] [Indexed: 11/18/2022] Open
Abstract
Background Some cardiovascular risk factors have been confirmed to be positively correlated with arterial stiffness. However, it is unclear whether HDL-C, a well-established anti-risk factor, has an independent association with arterial stiffness. The aim of this study was to evaluate the relationship between HDL-C levels and arterial stiffness and the possible role of high-sensitivity C-reactive protein (hs-CRP) in this potential correlation in apparently healthy adults undergoing a general health examination in China. Materials and Methods This was a cross-sectional survey. In total, 15,302 participants (age range, 18–82 years; mean, 43.88±8.44 years) were recruited during routine health status examinations. A questionnaire was used and we measured the body mass index, systolic and diastolic blood pressure, and fasting glucose, and serum lipid, uric acid, hs-CRP, and serum creatinine levels of each participant. Central arterial stiffness was assessed by carotid–femoral pulse wave velocity (cf-PWV). Results HDL-C levels decreased as cf-PWV increased. Pearson’s correlation analysis revealed that HDL-C levels were associated with cf-PWV (r=−0.18, P<0.001). hs-CRP levels were positively associated with cf-PWV (r=0.13). After adjustment for all confounders, HDL-C was inversely independently associated with all quartiles of cf-PWV. Furthermore, HDL-C was associated with cf-PWV in different quartiles of hs-CRP, and the correlation coefficients (r) gradually decreased with increasing hs-CRP levels (quartiles 1–4). Conclusions HDL-C is inversely independently associated with central arterial stiffness. The anti-inflammatory activity of HDL-C may mediate its relationship with cf-PWV. Further, long-term follow-up studies are needed to evaluate whether high HDL-C levels are protective against central artery stiffening through the anti-inflammatory activity of HDL-C.
Collapse
Affiliation(s)
- Xi Wang
- Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China
| | - YingZhen Du
- Department of Geriatric Respiratory, Chinese PLA General Hospital, Beijing, China
| | - Li Fan
- Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China
- * E-mail:
| | - Ping Ye
- Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China
| | - Ying Yuan
- Second Department of Internal Medicine, Affiliated Hospital of Institute of Aviation Medicine, Air Force, Beijing, China
| | - XueChun Lu
- Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China
| | - Fan Wang
- Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China
| | - Qiang Zeng
- International Medical Centre, Chinese PLA General Hospital, Beijing, China
| |
Collapse
|
24
|
Chang C, Guo B, Zhang L, Zhu HL, Lu XC, Fan H, Li SX, Yang B, Liu Y, Zhai B, Yang Y, Ran HH, Lin J. [Inhibitory effect of all-trans retinoic acid combined with SBA-Na on K562 and Kasumi-1 cell lines in vitro]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013; 21:879-85. [PMID: 23998578 DOI: 10.7534/j.issn.1009-2137.2013.04.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
This study was aimed to investigate the effect of all-trans retinoic acid (ATRA) combined with SBA-Na on the biologic activities of human leukemia K562 and Kasumi-1 cell lines and their mechanism. The ATRA solution of 10(-6) mol/L (W1), 10(-4) mol/L (W2) and the SBA-Na solution of 100 µg/ ml (Z1) and 200 µg/ml (Z2) were prepared respectively. The K562 and Kasumi-1 cells were treated with W1, W2, Z1, Z2, W1 + Z1 and W2 + Z2 respectively, at same time, the blank control was set up. The cell morphology and growth in different treated groups were observed under light microscope. The CCK-8 method was used to detect the proliferation ability of cells, the cell growth curves were drawn, the inhibitory rate of cells was calculated. The flow cytometry with PI single staining and PI/Annexin V double stainings was used to detect the change of cell cycle and apoptosis of 2 cell lines treated with different drugs. The RQ-PCR was used to detect the change of Cyclin A mRNA expression in K562 cells. The results showed both ATRA and SBA-Na displayed inhibitory effect on cell proliferation, and the combination of these two drugs had stronger effect. As compared with the control group, the cell cycle distribution were changed obviously, and the apoptosis increased more significantly in treated groups, especially in group of ATRA combined with SBA-Na. The Cyclin A mRNA expression was up-regulated in Z1 group, while Cyclin A mRNA expression was down-regulated in other groups. It is concluded that both ATRA and SBA-Na can inhibit the proliferation of K562 and Kasumi-1 cell lines and promote their apoptosis. This effect may be stronger when both drugs combined. For K562 cells, the inhibitory effect may be accomplished through down-regulation of Cyclin A mRNA.
Collapse
Affiliation(s)
- Cheng Chang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Xu XX, Yang JW, Lu XC, Liu LH. [Advances of studies on pathogenesis and management of paroxysmal nocturnal hemoglobinuria]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013; 21:530-5. [PMID: 23628070 DOI: 10.7534/j.issn.1009-2137.2013.02.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder of hematopoiesis due to the inactivation of PIG-A gene. However, the presence of mutant PIG-A gene in a group of hematopoietic cells is not enough for the development of PNH, immunologic injury and apoptotic effects are considered to play an important role in clonal expansion. Knowledge of the molecular mechanisms leading to PNH has substantially increased in the past decades, which remarkably advances the diagnostic modalities and treatment approaches of patients with PNH. Though great progress has been made because of targeted therapy method, the challenges are still ahead. In this review the advances of studies on mechanism, laboratorial diagnosis and therapeutic protocols of PNH are summarized.
Collapse
Affiliation(s)
- Xian-Xing Xu
- Department of Pharmacy, The Second Artillery General Hospital, Beijing, China
| | | | | | | |
Collapse
|
26
|
Li SX, Zhu HL, Guo B, Lu XC, Fan H, Lin J, Yang B, Liu Y, Yang Y, Ran HH, Zhai B, Han WD, Wang Y, Yao SQ. [Curative efficiency of rituximab combined with autologous cytokine induced killer cells on aged patient with orbital diffuse large B cell lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20:1117-1121. [PMID: 23114130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
The aim of this study was to observe the curative effects and safety of autologous cytokine induced killer (CIK) cells in treatment of aged patients with orbital diffuse large B cell lymphoma after rituximab therapy. The patient was given rituximab three times with low dose COP chemotherapy one time when he was diagnosed with orbital diffuse large B cell lymphoma. Two months later, the patient began to receive five cycles CIK cells infusion. One course of therapy was defined as follows: about (2-3)×10(9) of CIK cells (survival rate > 95%) was transfused twice and then rhIL-2 (1 MU daily) was subcutaneously administered for 10 consecutive days. Efficacy and adverse effect was observed during or after CIK cells infusion. The results showed that the peripheral blood mononuclear cells of the patient could be cultured and expanded into CIK cells. The majority of CIK cells was positive for CD3 and CD8 after culture. The CD3(+)CD56(+) cells markedly increased after culture. After two cycles of CIK cell infusion, the orbital lymphoma and possible involvement of the kidney disappeared. The patient obtained complete remission after five cycles of CIK cells infusion. The side effects of CIK cell treatment were minor. It is concluded that CIK cell infusion may prevent recurrence, prolong progression-free survival and improve quality of life after rituximab (alone or with chemotherapy) for aged patients with orbital diffuse large B-cell lymphoma.
Collapse
Affiliation(s)
- Su-Xia Li
- Department of Geriatric Hematology, PLA General Hospital, Beijng, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Gao Y, Fan L, Lu XC, Cao J, Zhao X, Pei J, Meng XY, Fan L. DRUG INTERACTION STUDIES OF ATORVASTATIN AND OTHER DRUGS BASED ON BIOINFORMATICS. Heart 2012. [DOI: 10.1136/heartjnl-2012-302920a.46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
28
|
Hu GL, Leng WX, Wang X, Lu XC, Liu AJ, Cui H, Cao J, Fan L. Irbesartan does not influence the antiplatelet effect of aspirin in spontaneously hypertensive rats. CNS Neurosci Ther 2012; 18:709-10. [PMID: 22742580 DOI: 10.1111/j.1755-5949.2012.00350.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2012] [Revised: 06/06/2012] [Accepted: 04/18/2012] [Indexed: 12/01/2022] Open
|
29
|
Yang B, Chi XH, Lu XC, Tuo S, Zhang F, Zhang WY, Tuo CW, Han WD, Yao SQ. [Research progress on immunocyte senescence - review]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20:782-787. [PMID: 22739202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
The function of immune system degenerates in an aging-dependent manner and this results in immunosenescence. Human immune system includes two parts: genetic/innate immunity and adaptive immunity. The former is involved in monocytes, nature killer cells, and dendritic cells, the later is involved in acquired B and T lymphocytes. During the aging of immunity system, the both parts of immunity are damaged to some degree. Generally, innate immunity seems well-retained and the acquired immunity is degenerative seriously with aging. Immunocyte senescence is closely related to the elderly decreased ability to control infectious disease, cancer and to their generally poor response to vaccination. This review summarized the research progress on immunosenescence characteristics in aged phase.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Liu XF, Lu XC, Cao J, Gao Y, Ma C, Luo Y, Fan L. [Impact of clopidogrel carboxylic metabolite SR26334 on gene expression profile of human umbilical vein endothelial cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20:710-716. [PMID: 22739187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
This study was purposed to characterize the effect of carboxylic acid metabolite (SR26334) of clopidogrel bisulfate deprived of antiplatelet efficacy on the spectrum of gene expression in the cultured human umbilical vein endothelial cell (HUVEC) line (EA.hy926), and to explore the potential molecule mechanism of SR26334 impact on HUVEC. By using a Affymetrix HU133 plus 2.0 oligonucleotide microarray, the alteration of gene expression spectrum induced by SR26334 in HUVEC was detected, the real-time PCR was used to confirm the results of selected differentially expressing genes. The results indicated that total 235 including 176 up-regulated and 59 down-regulated genes were obtained with change more than 1.5-fold after SR26334 (10 µmol/L) acted on HUVEC for 48 h. SR26334 affected the expression levels of genes involved regulation of transcription, transcription, positive regulation of transcription from RNA polymerase II promoter, cell cycle, cell division, protein amino acid dephosphorylation in HUVEC. It is concluded that carboxylic acid metabolite SR26334 of clopidogrel bisulfate modulates function of endothelial cells through different pathway at gene level.
Collapse
Affiliation(s)
- Xian-Feng Liu
- Department of Geriatric Hematology, General Hospital of Chinese PLA, Beijing, China
| | | | | | | | | | | | | |
Collapse
|
31
|
Cai LL, Yang Y, Yang B, Zhu HL, Lu XC, Zhang WY, Yu RL, Chi XH, Wang Y, Dai HR, Han WD, Fan H, Li SX, Liu Y, Ran HH, Lin J, Tuo S, Tuo CW, Zhang F, Cao JP, Yao SQ. [Short-term curative efficacy of autologous cytokine induced killer cells combined with low-dose IL-2 regimen containing immune enhancement by thymic peptide in elderly patients with B-cell chronic lymphocytic leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20:564-570. [PMID: 22739156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
This study was purposed to evaluate the safety and curative effect of autologous cytokine induced killer cells (CIK) combined with low-dose IL-2 regimen containing immune enhancement of thymic peptide on elderly patients with B-cell chronic lymphocytic leukemia (B-CLL). Thymic peptide α1 was subcutaneously given as the immunoenhancement agent at a dose of 1.6 mg/d, 14 days as one cycle. Peripheral blood mononuclear cells (PBMNC) from 5 patients with B-CLL were isolated once a week to induce ex vivo CIK cells through culture in the context of interferon (IFN)-γ, interleukin (IL)-2 and anti-CD3 monoclonal antibody. The PBMNC were separated from patients before and after 14 days as one cycle of thymic peptide α1 administration. Parameters of amplification ability, effector cells quantity, lymphocyte subgroups percentage and antitumor cytotoxicity were compared before and after thymic peptide administration. The 5 patients were treated with CIK cells combined with low-dose IL-2 regimen immediately after injection of thymic peptide α1. The CIK cells plus low-dose IL-2 regimen containing thymic peptide enhancement was defined as: thymic peptide α1 1.6 mg/d was subcutaneously administered once every other day; (4 - 6) ×10(9) of CIK cells were transfused followed by IL-2 subcutaneous administration of 1 mU/d on days 1-10, 28 days as one cycle. Clinical evaluation parameters including cellular immunity function, CLL related biomarkers, disease state and infectious frequency and degree were investigated before and after CIK cells infusion puls IL-2. The results showed that the amount of amplified CIK cells, the percentage and amplification times of effector cells and antitumor cytotoxicity more significantly increased after thymic peptide α1 treatment than before its use (P < 0.05). The total 46 cycles of CIK cells infusion plus IL-2 were completed in the 5 CLL patients. No adverse reaction was observed. After treatment of CIK cells plus IL-2, the general conditions of 5 CLL patients were to different extent improved. Simultaneously, percentages of CD3(+), CD3(+)CD8(+), and CD3(+)CD56(+) cells in peripheral blood remarked by raised (P < 0.05), the serum level of β2 microglobulin was significantly declined (P < 0.05), and the frequency and degree of infection was also decreased (P < 0.05). Following CIK cells plus IL-2 therapy, the transformation of disease state from partial remission (PR) to complete remission was seen in 3 patients, from stable disease (SD) to PR in 1 patient, and from progress of disease to SD in 1 patient. It is concluded that the regimen of autologous CIK cells combined with low-dose IL-2 containing immune enhancement of thymic peptide is safety and effective for the treatment of elderly patients with B-CLL.
Collapse
Affiliation(s)
- Li-Li Cai
- Department of Geriatric Laboratory Medicine, Chinese PLA General Hospital, Beijing, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Yang B, Lu XC, Yu RL, Chi XH, Zhang WY, Zhu HL, Yuan J, Zhao P. Diagnosis and treatment of rituximab-induced acute tumor lysis syndrome in patients with diffuse large B-cell lymphoma. Am J Med Sci 2012; 343:337-41. [PMID: 22270402 DOI: 10.1097/maj.0b013e318244db6f] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Acute tumor lysis syndrome (ATLS) is a recognized complication of the treatment of malignant lymphomas and is associated with significant morbidity and mortality. However, there have been few reports of the occurrence of ATLS in patients treated with rituximab. This study reports 2 patients with high-grade diffuse large B-cell non-Hodgkin's lymphoma who presented high tumor load, were sensitive to treatment and had multiple risk factors for ATLS. Both patients developed ATLS after treatment with rituximab and, despite aggressive supportive therapy, died of multiple organ failure. These cases illustrate that ATLS can occur after treatment with rituximab and that a high index of suspicion is necessary for the prompt diagnosis of ATLS.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Liu XF, Lu XC, Fan L, Gao Y, Ma C, Luo Y. [Impact of clopidogrel on gene profile of human umbilical vein endothelial cell line and bioinformatics analysis]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20:466-472. [PMID: 22541120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
This study was purposed to investigate the effect of clopidogrel on gene expression profile of cultured human umbilical vein endothelial cell (HUVEC) line (EA.hy926), and explore its potential molecule mechanism. A Affymetrix U133 plus 2.0 oligonucleotide microarray was applied to detect the alteration of gene expression profile induced by clopidogrel in HUVEC. Real time RT-PCR was used to verify the result of selected differentially expressing genes. The results showed that total 508 genes (including 139 up-regulated and 369 down-regulated genes) were obtained with differential expression more than 1.5-fold after clopidogrel (10 µmol/L) acted on HUVEC for 48 h. Clopidogrel affected the expression levels of genes involved protein binding, transcription factor activity, zinc ion binding, regulation of DNA-dependent transcription, transcription, RNA splicing and so on. It is concluded that the clopidogrel modulate function of endothelial cells by regulating sets of genes through different pathway.
Collapse
Affiliation(s)
- Xian-Feng Liu
- Department of Geriatric Hematology, General Hospital of Chinese PLA, Beijing, China
| | | | | | | | | | | |
Collapse
|
34
|
Ma C, Lu XC, Fan L, Luo Y, Yang B, Gao Y, Liu XF. [Effect of irbesartan on the proliferation, apoptosis and VEGF mRNA expression of human umbilical vein cell line ea. hy926 in vitro]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2012; 28:68-71. [PMID: 22493900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
OBJECTIVE To evaluate the effect of irbesartan on the proliferation, apoptosis, and VEGF mRNA expression of human umbilical vein cell line EA.hy926 in vitro. METHODS The human umbilical vein cell line EA.hyY926 were treated with various concentrations of irbesartan for 24 h. The cell proliferation after the treatment was detected by CCK8 assay, flow cytometry and FITC Annexin V/PI kit were used to detect changes in the cell apoptosis. RT-PCR was used to evaluate the expression of VEGF mRNA. RESULTS There were no changes in cell shape with various concentration of irbesartan. CCK-8 assay showed a greater rate of the cell proliferation in irbesartan group than that in control group with a dose-independent manner after 24 h treatment. After incubation with irbesartan, cell proliferation rate was significant (P < 0.05). FCM analysis showed no significantly changes in the cell apoptosis. Irbesartan increased the proliferation of EA.hy926 cells. At concentration of 1 x 10(-4), 1 x 10(-5), 1 x 10(-6) mol/L, VEGF mRNA expression enhanced either (P < 0.05). CONCLUSION Irbesartan could promote the proliferation and up-regulated VEGFmRNA expression in EA.hy926 cell line. This result suggested that in addition to antihypertensive effect, angiotensin receptor antagonist might be a novel therapeutic approach to chronic ischemic heart disease as heart failure.
Collapse
Affiliation(s)
- Cong Ma
- Geriatric Department of Cardiology, Institute of Gerontology and Geriatrics, General Hospital of PLA, Beijing 100853, China
| | | | | | | | | | | | | |
Collapse
|
35
|
Wang QS, Zhao Y, Lu XC, Dou LP, Lou FD, Yu L. [Silence mechanism of WT1 gene in leukemic cell line U937]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19:1107-1111. [PMID: 22040952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
This study was aimed to investigate the methylation status of WT1 gene in leukemia cell lines and its relation with expression of WT1 gene. The WT1 gene was silenced by DNA methylation or histone deacetylation, and the expression of WT1 gene was induced by using HDAC inhibitor and/or demethylation agent of DNA. Some leukemia cell lines (U937, HL-60, K562, KG1) were detected by RT-PCR, MS-PCR, restriction analysis, and DNA sequencing. U937 leukemic cells without WT1 mRNA expression were incubated with HDAC inhibitor Trichostatin A (TSA) and/or demethylation agent decitabine. The results showed that the U937 cells did not express WT1 gene, but HL-60, K562 and KG1 cells highly expressed WT1 gene; WT1 gene was unmethylated in HL-60 cells, but methylated in K562 and U937 cells. WT1 expression could be reactivated by co-incubation with TSA and decitabine, but not was observed by using single drug. It is concluded that WT1 promoter is methylated in some leukemia cells, however, the methylation can not affect its expression. DNA methylation and deacetylation of histones are synergistic to inhibit the expression of WT1 in leukemic U937 cells, the combination of TSA with decitabine can induce expression of WT1 gene.
Collapse
Affiliation(s)
- Quan-Shun Wang
- Department of Hematology, Chinese PLA General Hospital, Beijing, China.
| | | | | | | | | | | |
Collapse
|
36
|
Zhang WY, Yang B, Lu XC, Liu Y, Yang Y, Zhu HL. [Clinicopathological features of acute tumor lysis syndrome in elderly patients with malignant non-Hodgkin's lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19:953-958. [PMID: 21867622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
This study was purposed to investigate the clinicopathological features of acute tumor lysis syndrome (ATLS) in elderly patients with malignant non-Hodgkin's lymphoma, so as to explore its diagnosis and treatments. 2 cases of ATLS in elderly patients with non-Hodgkin's lymphoma were retrospectively analyzed, including progress of tumor, the level of laboratory examination, clinical manifestation and response to treatments. Data regarding clinical and biochemical parameters were collected. The results indicated that the 2 patients with non-Hodgkin's lymphoma were found to have high tumor burden, and were sensitive to anti-tumor treatments, and had many promoting factors of ATLS. 1 patient displayed hyperkalemia, but another displayed hypokalemia. Both patients were given allopurinol, hydration and alkalization, and one was given dialysis. But both died because of disease deterioration. ATLS rarely occurred in patients who were treated by rituximab only. But the patients with high grade NHL and high tumor burden maybe develop ATLS during 1 - 4 days after given rituximab. In conclusion, ATLS is one of factors of death in patients with malignant lymphoma. The clinical manifestation is not typical, and the diagnosis mainly depends on laboratory examination parameters. Earlier judgment, prophylaxis and effective treatment are important for improving prognosis of elderly DLBCL-NHL.
Collapse
Affiliation(s)
- Wen-Ying Zhang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
| | | | | | | | | | | |
Collapse
|
37
|
Liu Y, Bao EN, Yang B, Lu XC, Zhu HL, Han WD, Wang Y, Dai HR, Yao SQ. [Clinical study of autologous cytokine induced killer cell infusion treating for elderly patients with myelodysplastic syndrome]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19:787-792. [PMID: 21729572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Objective of this study was to evaluate the effectiveness and safety of autologous cytokine induced killer (CIK) cells combined with IL-2 in treatment of elderly patients with myelodysplastic syndromes (MDS). Peripheral blood mononuclear cells were isolated from 6 elderly MDS patients and were stimulated by cytokines in vitro to form CIK cells. The autologous CIK cells were then infused back into the corresponding patients. The regimen was repeated every 4 weeks. Effector cell proportion changes, adverse effects, effects on inflammation, hemoglobin level and blood transfusion were assessed after treatment. The results showed that after autologous CIK cell infusion, the percentages of CD3(+), CD3(+)CD8(+) and CD3(+)CD56(+) increased significantly (p < 0.05). No severe adverse effects were observed in all patients. It also significantly reduced inflammation frequency and shortened high fever duration. During stable stage of disease, the CIK cell infusion could reduce the red blood cell infusion amount and stabilize hemoglobin level. However, the natural course of transformation from myelodysplastic syndromes to high-risk subtypes could not be changed by CIK cell treatment. It is concluded that the autologous CIK cell infusion is a safe and effective therapy for geriatric myelodysplastic syndrome.
Collapse
Affiliation(s)
- Yang Liu
- Department of Geriatric Hematology, Institute of Basic Sciences, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Yang B, Cai LL, Chi XH, Lu XC, Zhang F, Tuo S, Zhu HL, Liu LH, Yan JW, Tuo CW. [Prediction and bioinformatics analysis of human gene expression profiling regulated by amifostine]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19:711-716. [PMID: 21729556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Objective of this study was to perform bioinformatics analysis of the characteristics of gene expression profiling regulated by amifostine and predict its novel potential biological function to provide a direction for further exploring pharmacological actions of amifostine and study methods. Amifostine was used as a key word to search internet-based free gene expression database including GEO, affymetrix gene chip database, GenBank, SAGE, GeneCard, InterPro, ProtoNet, UniProt and BLOCKS and the sifted amifostine-regulated gene expression profiling data was subjected to validity testing, gene expression difference analysis and functional clustering and gene annotation. The results showed that only one data of gene expression profiling regulated by amifostine was sifted from GEO database (accession: GSE3212). Through validity testing and gene expression difference analysis, significant difference (p < 0.01) was only found in 2.14% of the whole genome (460/192000). Gene annotation analysis showed that 139 out of 460 genes were known genes, in which 77 genes were up-regulated and 62 genes were down-regulated. 13 out of 139 genes were newly expressed following amifostine treatment of K562 cells, however expression of 5 genes was completely inhibited. Functional clustering displayed that 139 genes were divided into 11 categories and their biological function was involved in hematopoietic and immunologic regulation, apoptosis and cell cycle. It is concluded that bioinformatics method can be applied to analysis of gene expression profiling regulated by amifostine. Amifostine has a regulatory effect on human gene expression profiling and this action is mainly presented in biological processes including hematopoiesis, immunologic regulation, apoptosis and cell cycle and so on. The effect of amifostine on human gene expression need to be further testified in experimental condition.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Lin J, Zhu HL, Lu XC, Fan H, Li SX, Zhai B, Liu Y, Ran HH, Yang B. [Clinical analysis of 12 acute leukemia patients aged over 80 years]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19:139-142. [PMID: 21362239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
The objective of this study was to explore the clinical features of acute leukemia patients aged over 80 years. 12 cases of acute leukemia patients aged over 80 years who were diagnosed from 2000 to 2010 years were analyzed retrospectively. 9 cases suffered from acute myelogenous leukemia and 3 cases were with acute lymphoblastic leukemia. All patients were with several complicated diseases and the general status was poor in most patients. 10 cases received individualized treatments. The results showed that 2 patients achieved complete remission, but in other patients was not observed remission and the mean survival time was 20 ± 16 weeks. In AML patients, the mean survival time was 27 ± 14 weeks which was obviously longer than that in other reports. The survival time in 3 ALL patients was shortest. In conclusion, survival time was prolonged obviously in AML patients well advanced of age after individualized treatments, but prognosis of ALL in aged patients was very poor, for whom there is no relatively effective treatment.
Collapse
Affiliation(s)
- Jie Lin
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Yang B, Lu XC, Zhang F, Fan H, Li SX, Zhu HL. [Inhibitory effect of Tanreqing injection on proliferation of T lymphoblastic leukemia cell line Molt4 in vitro and its mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19:44-49. [PMID: 21362219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
This study was purposed to explore the effects of Tanreqing injection on the biologic activities of human acute T lymphoblastic leukemia cell line Molt4 in vitro and its mechanism. Tanreqing injection was proportionally diluted and divided into 9 groups of different concentrations, including 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128, 1:256 and 1:512. Molt4 cells were treated with those different concentrations of Tanreqing injection, and the cell growth status at various time points of different concentrations was observed under microscope. CCK-8 assay was employed to detect ability of cell proliferation, growth curve was drawn, the inhibition ratio and 50% inhibiting concentration (IC(50)) were calculated. Flow cytometry with PI and PI/Annexin V double stainings were used to detect the cell cycle and apoptosis of Molt4 cells after the treatment of Tanreqing injection respectively. Caspase-3 and Bcl-2 mRNA expression of Molt4 cells were determined by real-time quantitative PCR. The results showed that Tanreqing injection displayed an inhibitory effect on the proliferation of Molt4 cell line. In 1:2, 1:4, 1:8 and 1:16 concentration groups, great cytotoxicity was observed and numerous cells were dead. The inhibitory effect of Tanreqing injection was dose-dependent. IC(50) was 1:142 dilution concentration. In the 1:32 concentration group, S phase cell quantity remarkably decreased (p < 0.05) and apoptosis rate significantly increased (p < 0.05) at 72 hours after Tanreqing injection treatment. Simultaneously, caspase-3 mRNA expression increased and Bcl-2 mRNA expressions was downregulated (p < 0.05). It is concluded that the Tanreqing injection has an inhibitory effect on Molt4 cell proliferation and promotes its apoptosis. These biological effects of Tanreqing injection are partly related to cell reduction in S phase, downregulation of bcl-2 gene and upregulation of caspase 3.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | |
Collapse
|
41
|
Guo B, Zhu HL, Li SX, Lu XC, Fan H. Individualized Liposomal Doxorubicin-Based Treatment in Elderly Patients with Non-Hodgkin’s Lymphoma. ACTA ACUST UNITED AC 2011; 34:184-8. [DOI: 10.1159/000327008] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
42
|
Fan H, Zhu HL, Li SX, Lu XC, Zhai B, Guo B, Yao SQ, Liu Y. Efficacy of Amifostine in Treating Patients with Idiopathic Thrombocytopenia Purpura. Cell Biochem Biophys 2010; 59:7-12. [DOI: 10.1007/s12013-010-9100-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
43
|
Cai LL, Yang B, Lu XC, Zhu HL, Han WD, Wang Y, Liu Y, Dai HR, Yao SQ. [Application of immune function test to evaluate effect of cytokine-induced autologous killer cell infusion for elderly patients with hematological malignancies]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010; 18:1250-1255. [PMID: 21129270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
The aim of study was to explore the efficacy of cytokine induced autologous killer (CIK) cell infusion as an immune therapy for elderly patients with hematological malignancies. Peripheral blood mononuclear cells (PBMNC) were isolated from 20 elderly patients with hematological malignancies, and then augmented by priming with human recombinant interferon gamma (rhIFN-γ) followed by human recombinant interleukin 2 (rhIL-2) and monoclonal antibody (mAb) against CD3. The obtained autologous CIK cells [(2-3)×10(9)] were infused back to individual patients, then followed by subcutaneous injection of IL-2 at single daily dose of 1×10(6) U for 10 consecutive days. The regimen was repeated every 4 weeks and total 136 cycles of CIK cells transfusion were completed. The changes in cellular immune function, tumor-related biological parameters, imaging characteristics, the condition of remission, quality of life (QOL) and survival were assessed. The results indicated that 14 patients received 8 cycles of CIK cells infusion, and 4 cycles were completed in 6 patients. No adverse reaction was observed in all patients. The percentages of CD3+, CD3+CD8+ and CD3+CD56+ cells increased significantly (p<0.05), and serum levels of β2-microglobulin and LDH markedly decreased (p<0.05) after autologous CIK cells transfusion. The tumor-related symptoms were relieved, QOL obviously improved (p<0.01) in all patients. Complete remission was seen in 11 patients, and partial remission was observed in 7 patients. It is concluded that the autologous CIK cell infusion can improve immunity in elderly patients of hematological malignancies and displays its effectiveness and safety for elderly patients.
Collapse
Affiliation(s)
- Li-Li Cai
- Department of Geriatric Laboratory Medicine, Institute of Basic Medical Sciences, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Yang B, Lu XC, Zhu HL, Han WD, Wang Y, Fan H, Li SX, Liu Y, Dai HR, Yao SQ. [Clinical study of autologous cytokine induced killer cells combined with IL-2 for therapy of elderly patients with B-cell malignant lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010; 18:1244-1249. [PMID: 21129269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Objective of this study was to evaluate the effectiveness and safety of autologous cytokine induced killer (CIK) cells combined with IL-2 in treatment of elderly patients with B-cell malignant lymphoma. Peripheral blood mononuclear cells (PBMNC) were isolated from 9 elderly patients with B-cell malignant lymphoma, and then induced into CIK cells by IFN-γ, IL-2 and monoclonal antibody (mAb) against CD3. The autologous CIK cells [(2-3)×10(9)] thus obtained were infused back to individual patients, then followed by subcutaneous injection of IL-2 at single daily dose of 1×10(4) U/day for 10 consecutive days. The regimen was repeated every 4 weeks and total 64 cycles of CIK cell transfusion were completed. The changes in cellular immune function, tumor-related biological parameters, imaging characteristics, the condition of remission, quality of life and survival time were assessed. 7 patients received 8 cycles of CIK cell infusion, and 4 cycles were completed in 2 patients. The results showed that no adverse reaction was observed in all above mentioned patients. The percentages of CD3+, CD3+CD8+ and CD3+CD56+ increased significantly (p<0.05), and serum levels of β2-microglobulin and LDH were markedly decreased (p<0.05) after autologous CIK cell transfusion. The lymphoma symptoms were relieved with quality of life obviously elevated (p<0.01) in all patients. Complete remission was seen in 8 patients. Though one patient received 8 cycles of CIK cell transfusion therapy and achieved transient very good partial remission, but he died of acute large-area myocardial infarction and persistent progression of lymphoma. In conclusion, regimen of autologous CIK cells combined with IL-2 is safe and effective for the therapy of elderly patients with B-cell malignant lymphoma.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, Institute of Basic Medical Sciences, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Li W, Huang Y, Yang B, Chi XH, Liu LH, Zhang F, Yan JW, Lu XC. [Cloning of ID4 gene expression regulation promoter and subcloning of recombinant ID4 promoter luciferase reporter]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010; 18:421-426. [PMID: 20416180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
UNLABELLED The present study was aimed to clone ID4 gene promoter and upstream regulatory region, and to construct a series of recombinant promoter-luciferase reporter for exploring the mechanism of ID4 gene expression regulation. METHODS AND RESULTS the upstream 5' flanking sequence of 2242 bp from transcriptional start site (TSS) and downstream 5' non-coding region of 212 bp on ID4 gene were searched out and downloaded from human genome databank of NCBI using whole length of ID4 gene cDNA as a probe; On-line promoter analysis softwares, including TESS and Genomax, were employed to analyze the characteristics of ID4 gene promoter and upstream regulatory elements. Then, based on the analytic results, PCR primers were designed and synthesized. Segmental amplification method was adopted to obtain two fragments of 1829 bp and 784 bp. The two fragments were inserted into the plasmid pGEM-T, transformed into TOP10 competent E. coli., and positive recombinants were screened respectively. Subsequently, restriction enzymes KpnI/NheI and KpnI/EcoRI were used to digest the above-mentioned two plasmids pGEM-T and pGL3, and ligation was completed by T4 DNA ligase. After transformation to TOP10 competent E. coli. and screening of positive colonies, the basic recombinant ID4 gene promoter-pGL3 was successfully constructed. KpnI/NheI double digestion and sequencing showed that the target fragment was 2 459 bp and consistent with the corresponding sequence of GenBank; Using the 2459 bp fragment as a template, 5 pairs of primers with identical 3' terminus and different 5' terminus were designed and synthesized for half-nest PCR amplification. 5 fragments with an interval of approximate 400 bp each other, i.e. 2112 bp, 1703 bp, 1290 bp, 784 bp and 496 bp, were produced and inserted into pGEM-T after recovery and purification for transformation to TOP10 competent E. coli. and screening of positive colonies. After that, KpnI/NheI was used to digest the above-mentioned five pGEM-T recombinant plasmids and pGL3 basic vector, and the ligation was completed by T4 DNA ligase. After transformation to TOP10 competent E. coli. and screening for positive colonies, 5 subcloned recombinants of ID4 gene promoter and pGL3 Basic vector cells were constructed. In conclusion, 2.5 kb ID4 gene promoter with upstream expression regulatory sequence was successfully cloned and a series of ID4 promoter subclone-pGL3-Basic recombinant were constructed for further researches on activity, expression regulation and function of ID4 promoter.
Collapse
Affiliation(s)
- Wei Li
- Center of Oncology, The First Affiliated Hospital of Jilin University, Changchun 130021, Jilin Province, China
| | | | | | | | | | | | | | | |
Collapse
|
46
|
Lu XC, Chi XH, Yang B, Zhu HL, Liu LH, Zhang F, Yan JW. [Gene expression profile analysis of T lymphocytes involved in pathogenesis of severe aplastic anemia by using bioinformatics method as a novel way of drug screening]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010; 18:416-420. [PMID: 20416179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
This study was aimed to explore the gene expression profile characteristics of T lymphocytes involved in pathogenesis of severe aplastic anemia (SAA) and to predict putative curative drugs for SAA by using biological principle of similarity contrast of gene expression profiles between drugs and diseases. SAA and T lymphocyte were used as key words to search gene expression datasets related to pathogenesis of SAA in public Gene Expression Omnibus (GEO) of NCBI. After significance test, gene expression profiling involved in pathogenesis of SAA were screened and applied to cluster analysis. And then SAA-related gene expression profiles were thrown into pharmacological gene expression datasets of 3000 candidate drugs for similarity analysis and significantly negative correlation was used as a screening criterion for selecting putative curative drugs of SAA. The results showed that only one gene expression dataset was found out, i.e. GSE3807. Computational bioanalysis identified a total of 515 candidate genes of T lymphocyte involved in pathogenesis of SAA, whose expression level exceeded more than 2-fold. Among them, 202 genes were upregulated and 313 genes were downregulated. Cluster analysis showed that those genes belonged to different pathways, including nucleic acid metabolic process, ubiquitin-dependent protein catabolic process, Golgi apparatus protein transport, protein phosphorylation and immunoglobin/major histocompatibility complex. Similarity analysis of gene expression profiles of SAA and drugs showed that hydroxycamptothecin and metformin might have a potential therapeutic efficacy on SAA. It is concluded that by means of novel bioinformatics method, gene expression profiling combined with similarity analysis between disease-related gene expression and pharmacological gene expression profiles may be a novel way of drug screening for SAA.
Collapse
Affiliation(s)
- Xue-Chun Lu
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China.
| | | | | | | | | | | | | |
Collapse
|
47
|
Abstract
BACKGROUND AND OBJECTIVE LRP16 is a human novel gene linked to leukemia identified recently. However, its biological function is not fully clarified so far. This study was to investigate the biological function of human LRP16 gene by database-aided bioinformatics analysis. METHODS The structures and functions of LRP16 gene promoter and its coding protein were analyzed using bioinformatics prediction, and further experimental testing was performed. The recombinants of pGL3-basic and LRP16 promoter subclones were constructed for luciferase activity analysis. The recombinant of LRP16 open reading frame coding sequence and pcDNA3.1 eukaryotic expression vector was established and transfected into HL-60 and K562 cell lines. DNA damage of HL-60 cells after ultraviolet irradiation was evaluated using single cell gel electrophoresis. Cell cycle of K562 cells was analyzed by flow cytometry. RESULTS LRP16 promoter was a typical class II eukaryotic promoter and its core regulation sequence was located within upstream -600 bp of transcriptional start site. In addition, seven cis-acting elements, which may be implicated in cell cycle, hematopoiesis regulation, cell proliferation and repair of DNA damage, were identified. Long type LRP16 coding protein contained homologous sequences of hismacro, COG2110, and A1pp with human histone H2A1C between 148 and 315 amino acid residue. The number of comet cells and the length of comet tail in HL-60 cells irradiated were significantly decreased and the number of living cell was significantly increased in LRP16-overexpression group compared with empty plasmid control group. The proliferation rate and ratio or quantity of G2/M and S phases were significantly increased in LRP16-overexpression K562 group compared with empty plasmid control group. LRP16-overexpression in K562 cells promoted the transition of G1 to S phase and plateau phase of cell proliferation was advanced. CONCLUSIONS Promoter regulation prediction and protein domain analysis based on bioinformatics contribute to the study of gene function. LRP16 may play an important role in leukemia progression by promoting cell proliferation, regulating cell cycle, and antagonizing radiation-induced DNA damage.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, PLA General Hospital, Beijing 100853, P. R. China
| | | | | | | | | | | |
Collapse
|
48
|
Yang B, Lu XC, Chi XH, Han WD, Yu L, Lou FD. [Promotive effect of LRP16 gene on proliferation of K562 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009; 17:1154-1158. [PMID: 19840441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The study was aimed to investigate the promotive effect of LRP16 gene on K562 cell proliferation. Open reading frame of LRP16 gene was amplified using reverse transcription-polymerase chain reaction (RT-PCR) and ligated to pGEM-T plasmid to construct LRP16 ORF-pGEM-T recombinant vector. Then, LRP16 ORF identified by sequencing was inserted into pcDNA3.1+ plasmid to construct LRP16 ORF-pcDNA3.1+ recombinant expression plasmid which was transfected into K562 cell lines to make overexpression of LRP16 gene in K562 cells. Survival of cells was determined by MTT assay and growth curve of cells was drawn, the cell cycle was detected by flow cytometry. The results showed that LRP16 ORF was successfully amplified, then the LRP16 ORF-pcDNA3.1+ recombinant plasmid was constructed. The K562 cell line with overexpression of LRP16 gene was established. The promotive effect of LRP16 gene overexpression on proliferation of K562 cells was observed and the effect partially related to the enhancement of cells from G0 to S phase induced by LRP16 gene. It is concluded that LRP16 gene overexpression shows a promotive effect on proliferation of K562 cells.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | |
Collapse
|
49
|
Yang B, Chi XH, Lu XC, Han WD, Yu L, Lou FD. [Lrp16 gene expression in leukemia cell lines and bone marrow cells of leukemia patients and its clinical implication]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009; 17:857-860. [PMID: 19698216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
This study was purposed to investigate lrp16 gene expression in leukemia cell lines and bone marrow cells of leukemia patients and explore the relationship between lrp16 gene expression and development of leukemia. Reverse transcriptase-polymerase chain reaction (RT-PCR) was employed to test the lrp16 mRNA expression in 4 leukemia cell lines, including K562 (CML), HL-60 (APL), MOLT4 (ALL) and U937 cell lines, as well as in bone marrow-derived cells from 115 patients with leukemia. The effect of lrp16 gene expression on genesis and progression of leukemia was analyzed according to clinicopathological features. The results indicated that positive expression of lrp16 mRNA was found in all 4 leukemia cell lines. For leukemia patients, the positive expression rate of lrp16 mRNA in all AML patients was 38% (16/42), in which the positive rates in AML patients with complete remission (CR) and AML patients without remission were 13% (4/30) and 100% (12/12) respectively. The positive expression rate of lrp16 mRNA in ALL patients was 38% (10/26), in which the positive rate in ALL patients with CR and ALL patients without remission were 16% (3/18) and 87% (7/8) respectively. The positive expression rate of lrp16 mRNA in CML patients was 36% (9/25), in which the positive rates in CML patients with CR and CML patients without remission were 20% (4/20) and 100% (5/5) respectively. The positive rate of lrp16 mRNA in CLL patients was 31% (7/22), in which the positive rate in CLL patients with CR and CLL patients without remission were 11% (2/17) and 100% (5/5) respectively. There was no difference of lrp16 gene expression between leukemia subtypes, but there was statistical significant difference in lrp16 gene expression between CR patients and non CR patients (p < 0.001). It is concluded that the lrp16 gene is a leukemic oncogene and closely relates to genesis and progression of leukemia, which may be an indicator for evaluating clinical efficacy of leukemia therapy.
Collapse
Affiliation(s)
- Bo Yang
- Department of Geriatric Hematology, PLA General Hospital, Beijing 100853, China
| | | | | | | | | | | |
Collapse
|
50
|
Chi XH, Liu LH, Lu XC, Yang B, Dong M. [Bioinformatics scan of factors with inhibitory effect on lrp16 gene expression]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009; 17:953-956. [PMID: 19698236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The main purpose of the this study was to find the candidate cis-elements in negative regulation region throngh analysing the DNA sequences of lrp16 gene promoter so as to provide the experimental basis for screening drugs with inhibitory effect on lrp16 gene expression. The open reading frame (ORF) sequences in uncoding DNA and mRNA sequences of 5' flanking region in lrp16 gene were cloned by the data in GeneBank and Internet; the possibly existing cis-element in thsi region was searched in databank of human transcriptional factor by using TESS and Genomax online promoter analysis software; the drugs related to inhibition of lrp16 gene expression were screened by using SAGE and GEO databank. The results showed that there were many cis-elements in the negative regulation region, including T-Ag, PU.1, c-Ets, XPF-1, P2 alphaA, IL6-6RE and RAR. In cultured cell lines, hormone or its inhibitor such as corticosteroid, tamoxifen, forskolin, phenylephrine, inflammatory factors such as IFNgamma and TNFalpha, and chemotherapeutics 5-fluorouracil could down-regulate the lrp16 gene expression as compared with absent ones. It is concluded that cis-elements including T-Ag, PU.1, c-Ets, XPF-1, P2 alphaA, IL6-6RE and RAR may inhibit lrp16 expression and hormone or its inhibitor such as corticosteroid, tamoxifen, forskolin, phenylephrine, inflammatory factors such as IL6, IFNgamma and TNFalpha, and chemotherapeutics 5-fluorouracil may participate in the regulation of lrp16 gene expression in negative manner.
Collapse
Affiliation(s)
- Xiao-Hua Chi
- Department of Pharmacy, 262th Hospital of PLA, Beijing 100800, China
| | | | | | | | | |
Collapse
|